
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<p>Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins</p>
Yongjie Niu, Shan Liang, Han Gao, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12015-12025
Open Access | Times Cited: 16
Yongjie Niu, Shan Liang, Han Gao, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12015-12025
Open Access | Times Cited: 16
Showing 16 citing articles:
Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges
Kexin Li, Kunmin Xiao, Shijie Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Kexin Li, Kunmin Xiao, Shijie Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma
Yichen Peng, Xia Wu, Yurong Zhang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2305-2321
Open Access | Times Cited: 9
Yichen Peng, Xia Wu, Yurong Zhang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2305-2321
Open Access | Times Cited: 9
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma
Ke Shi, Yufei Bi, Xuanwei Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Ke Shi, Yufei Bi, Xuanwei Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysis
Shaoju Luo, Hao Hu
Journal of Ethnopharmacology (2022) Vol. 301, pp. 115774-115774
Open Access | Times Cited: 10
Shaoju Luo, Hao Hu
Journal of Ethnopharmacology (2022) Vol. 301, pp. 115774-115774
Open Access | Times Cited: 10
Secondary Metabolites from the Cultures of Medicinal Mushroom Vanderbylia robiniophila and Their Tyrosinase Inhibitory Activities
Yu-Xi Wang, Jinghui Jia, Qi Wang, et al.
Journal of Fungi (2023) Vol. 9, Iss. 7, pp. 702-702
Open Access | Times Cited: 5
Yu-Xi Wang, Jinghui Jia, Qi Wang, et al.
Journal of Fungi (2023) Vol. 9, Iss. 7, pp. 702-702
Open Access | Times Cited: 5
The natural medicinal fungus Huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death
Zhengguang Zhang, Cunsi Shen, Fuqiong Zhou
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 9
Zhengguang Zhang, Cunsi Shen, Fuqiong Zhou
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 9
D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer
Yongxi Zhang, Huijie Jia, Zhiang Liu, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108203-108203
Open Access | Times Cited: 9
Yongxi Zhang, Huijie Jia, Zhiang Liu, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108203-108203
Open Access | Times Cited: 9
Metabolomic comparison between natural Huaier and artificial cultured Huaier
Tongtong Jian, Yu Zhang, Guoying Zhang, et al.
Biomedical Chromatography (2022) Vol. 36, Iss. 6
Closed Access | Times Cited: 5
Tongtong Jian, Yu Zhang, Guoying Zhang, et al.
Biomedical Chromatography (2022) Vol. 36, Iss. 6
Closed Access | Times Cited: 5
Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression
Feifeng Tang, Long Liu, Xiaoting Tian, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Feifeng Tang, Long Liu, Xiaoting Tian, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
The treatment effects of Trametes Robiniophila Murr against colorectal cancer: A mini-review
Bo Li, Qian Cao, Zhuo Liu
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Bo Li, Qian Cao, Zhuo Liu
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
A Critical Assessment for Hualer, A Traditional Chinese Medicine, for Cancer Therapy: Medicinal Characteristics, Molecular Mechanisms of Action, In-Vitro and In-Vivo Anticancer Activities, and Future Research Directions
Xinuo Zhang, Shengqiang Tong, JiangāJiang Qin, et al.
Deleted Journal (2024) Vol. 2, Iss. 1, pp. 29-47
Open Access
Xinuo Zhang, Shengqiang Tong, JiangāJiang Qin, et al.
Deleted Journal (2024) Vol. 2, Iss. 1, pp. 29-47
Open Access
Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis
Kailing Xie, Mingxiu Ma, Feng Xu
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Kailing Xie, Mingxiu Ma, Feng Xu
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics
Yuxiang Wan, Honglin Jiang, Zeyu Liu, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 24, pp. 1894-1911
Closed Access
Yuxiang Wan, Honglin Jiang, Zeyu Liu, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 24, pp. 1894-1911
Closed Access
The potential therapeutic benefits of Huaier in digestive system cancer: Its chemical components, pharmacological applications and future direction
Hong Tang, Yujuan Yi, Yuru Yang, et al.
Journal of Functional Foods (2024) Vol. 118, pp. 106267-106267
Open Access
Hong Tang, Yujuan Yi, Yuru Yang, et al.
Journal of Functional Foods (2024) Vol. 118, pp. 106267-106267
Open Access
Combinatorial treatment with traditional medicinal preparations and VEGFR-tyrosine kinase inhibitors for middle-advanced primary liver cancer: A systematic review and meta-analysis
Huibo Yu, Jiaqi Hu, Bao-Jin Han, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313443-e0313443
Open Access
Huibo Yu, Jiaqi Hu, Bao-Jin Han, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313443-e0313443
Open Access
Network pharmacological analysis of corosolic acid inhibits hepatocellular carcinoma progression through P4HA2
Feifeng Tang, Long Liu, Xiaoting Tian, et al.
Research Square (Research Square) (2022)
Open Access
Feifeng Tang, Long Liu, Xiaoting Tian, et al.
Research Square (Research Square) (2022)
Open Access